Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine
Clicks: 330
ID: 119618
2001
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
82.5
/100
324 views
263 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In Guinea-Bissau, children were randomised at 6 months of age to receive either two doses of standard-titre measles vaccine at 6 and 9 months of age or an inactivated polio vaccine at 6 months and standard-titre measles vaccine at 9 months of age. During the first 5 months, children received Edmonst …
| Reference Key |
ml2001vaccinemeasles
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Garly ML;Balé C;Martins CL;Monteiro M;George E;Kidd M;Dias F;Aaby P;Whittle HC;; |
| Journal | Vaccine |
| Year | 2001 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
immunization
immunity
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
age factors
Infant
Clinical Trial
Randomized Controlled Trial
Antibodies
Measles / prevention & control
Measles Vaccine / administration & dosage*
viral / blood
dose-response relationship
immunization schedule
h c whittle
measles virus / immunology
viral / biosynthesis*
measles vaccine / immunology*
guinea-bissau
immunologic
maternally-acquired
secondary
pmid:11228365
doi:10.1016/s0264-410x(00)00431-x
m l garly
c balé
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.